Extensive Lung Cancer - Small Cell
VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer (June 7, 2008)
VePesid®/Platinol® Remains Standard-of-care for Small Cell Lung Cancer For patients diagnosed with extensive-stage small-cell lung cancer (SCLC), the standard-of-care remains the chemotherapy combination... Continue Reading
Increasing the dose intensity of chemotherapy does not appear to improve survival in small cell lung cancer. These results were recently published in the Journal of the National Cancer Institute. Small... Continue Reading
PET Scans May Help Identify Early Lung Cancer According to an article recently published in the Journal of the National Cancer Institute, positron emission tomography (PET) scans may improve the accuracy... Continue Reading
Camptosar® plus Paraplatin® Effective for Small Cell Lung Cancer According to the results of a study presented at the 12th World Lung Cancer Conference, chemotherapy with Camptosar® (irinotecan) and... Continue Reading
Advances in the Management of Small-Cell Lung Cancer: Highlights from the 12th World Conference on Lung Cancer Introduction Approximately 25,000 patients are diagnosed with small-cell lung cancer (SCLC)... Continue Reading
Avastin® Added Safely to Paraplatin® and Camptosar® for Small Cell Lung Cancer According to the results of a study presented at the 12th World Conference on Lung Cancer, the targeted therapy Avastin®... Continue Reading
Aranesp® Reduces Blood Transfusions Without Negative Effects on Survival in SCLC According to results recently presented at the 2007 World Conference on Lung Cancer in Seoul, Korea, use of Aranesp® (darbepoetin... Continue Reading
Radiation to the Brain Should Become Standard Therapy for Extensive-disease Small Cell Lung Cancer According to results recently published in the New England Journal of Medicine, prophylactic cranial radiation... Continue Reading
Camptosar®/Paraplatin® Improves Survival in Small Cell Lung Cancer According to results recently presented at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO), the chemotherapy... Continue Reading
Prophylactic Cranial Radiation Improves Survival in Extensive Small-Cell Lung Cancer According to results recently presented at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO),... Continue Reading



